COVID vaccine hesitancy among African American hemodialysis patients: A singleヽenter experiencedoi:10.1111/hdi.12922Dhakrit RungkitwattanakulAndrew YabusakiDivita SinghPamela LawsonConstance MereHemodialysis International
Some 579 million of the total 818 million COVID-19 vaccine doses have been administered, which corresponds to 70.7 percent of the total supply available in Africa, the Africa CDC said. Countries such as Seychelles, Mauritius, Rwanda, Morocco, and Botswana have vaccinated the largest share of t...
In contrast, the overall pooled prevalence rate of COVID-19 vaccination hesitancy for African-Americans was 41.6% (95%Ci=34.4-48.9) and for Hispanics, it was 30.2% (95%Ci=23.2-37.7). The major predictors of vaccine hesitancy in African-Americans and Hispanics were: sociodemographic ...
By November 12, 2021, China had provided over 1.7 billon doses of Covid-19 vaccine to more than 110 countries and organizations, including 50 African countries and the AU Commission, and is striving to provide a total of 2 billion doses by the end of 2021. In addition to donating $100...
[9]. Africa’s low vaccination rate is a threat to global recovery from the effects of COVID-19 [10]. A significant proportion of the funding for COVID-19 in Africa has been by the individual governments which has the potential to divert resources from planned activities and consequently ...
COVID-19 vaccine shipments to African countries have slowed down in May due to "the reliance on India as one of the key manufacturers globally, and the devastating surge of cases India is dealing with," a World Health Organization (WHO) regional director said on Thursday, according to Anadolu...
He added that Egypt had made a notable leap in the production of the COVID-19 vaccines, through cooperation with China's Sinovac company, noting that the new move would make Egypt a regional hub for vaccine production. The Egyptian state-owned vaccine maker VACSERA and Chinese biopharmaceutical...
Currently, COVID-19 is in the state of “pandemic”. However, with the situation of no specific drug and the prolonged vaccine development cycle (Paul and Katherine, 2020), effective intervention measures will play a crucial role, and all the world should aggregate to contain the spread of ...
Prof. Taube and his team also compared neutralizing antibody levels following administration of one and two doses of the vaccine, as opposed to levels in patients that have recovered from Covid-19. They found that vaccination provided optimal levels of protection, whe...
Another COVID strain emerging in Nigeria? "It's not a given that the vaccine will not work on this variant, but it is a consideration that the vaccine might not have the full efficacy," he said. Well-timed trials Both Oxford and U.S. pharmaceutical giant Johnson & Johnson have carried...